Safety and effectiveness of IV Thrombolysis in retinal artery occlusion: A multicenter retrospective cohort study.

Publication

Safety and effectiveness of IV Thrombolysis in retinal artery occlusion: A multicenter retrospective cohort study.

Journal Paper/Review - Jul 7, 2023

Baumgartner Philipp, Kook Lucas, Altersberger Valerian L, Gensicke Henrik, Ardila Jurado Elena, Kägi Georg, Salerno Alexander, Michel Patrik, Gopisingh Kiran M, Nederkoorn Paul J J, Scheitz Jan F, Nolte Christian H, Heldner Mirjam R, Arnold Marcel, Cordonnier Charlotte, Della Schiava Lucie, Hametner Christian, Ringleb Peter Arthur, Leker Ronen R, Jubran Hamza, Luft Andreas R, Engelter Stefan T, Wegener Susanne, Thrombolysis in Stroke Patients (TRISP) Collaborators

Citation

Baumgartner P, Kook L, Altersberger V, Gensicke H, Ardila Jurado E, Kägi G, Salerno A, Michel P, Gopisingh K, Nederkoorn P, Scheitz J, Nolte C, Heldner M, Arnold M, Cordonnier C, Della Schiava L, Hametner C, Ringleb P, Leker R, Jubran H, Luft A, Engelter S, Wegener S, Thrombolysis in Stroke Patients (TRISP) Collaborators. Safety and effectiveness of IV Thrombolysis in retinal artery occlusion: A multicenter retrospective cohort study. Eur Stroke J 2023; 8:966-973.

Type

Journal Paper/Review (English)

Journal

Eur Stroke J 2023; 8

Publication Date

Jul 7, 2023

Issn Electronic

2396-9881

Pages

966-973

Brief description/objective

Retinal artery occlusion (RAO) may lead to irreversible blindness. For acute RAO, intravenous thrombolysis (IVT) can be considered as treatment. However, due to the rarity of RAO, data about IVT safety and effectiveness is limited.